Janney Montgomery Scott’s ADMA Biologics ADMA Stock Holding History

Janney Montgomery Scott’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$118K	Sell	14,126 -62,992	-82%	-$574K	﹤0.01%	3055
2026 Q1	$695K	Buy	77,118 +7,744	+11%	+$122K	﹤0.01%	1855
2025 Q4	$1.26M	Buy	69,374 +2,579	+4%	+$43.5K	﹤0.01%	1598
2025 Q3	$979K	Buy	66,795 +15,448	+30%	+$265K	﹤0.01%	1705
2025 Q2	$935K	Sell	51,347 -19,644	-28%	-$401K	﹤0.01%	1616
2025 Q1	$1.41M	Buy	70,991 +4,865	+7%	+$84.1K	﹤0.01%	1335
2024 Q4	$1.13M	Sell	66,126 -6,603	-9%	-$124K	﹤0.01%	1473
2024 Q3	$1.45M	Buy	+72,729	New	+$1.13M	﹤0.01%	1304

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Janney Montgomery Scott's ADMA Position: Q2 2026 in Review

Janney Montgomery Scott reduced its ADMA Biologics (ADMA) stake by 82% in Q2 2026, selling an estimated $574K and leaving 14,126 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Janney Montgomery Scott first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.45M in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Janney Montgomery Scott held 14,126 shares of ADMA Biologics worth $118K as of Q2 2026.
Janney Montgomery Scott sold 62,992 ADMA Biologics shares in Q2 2026, an estimated $574K.
ADMA Biologics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #3055 holding.
Janney Montgomery Scott first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
Janney Montgomery Scott's ADMA Biologics position peaked at $1.45M in Q3 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.